Publications by authors named "Susan Moran"

Claim this Profile
F
Familial isolated pituitary adenoma is independent of genotype in a novel mouse model of disease.
Anna L Shen, Susan M Moran, Edward N Glover, Bernice C Lin, Patrick R Carney

Heliyon· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RYZ101 (Ac-225 DOTATATE) Opportunity beyond Gastroenteropancreatic Neuroendocrine Tumors: Preclinical Efficacy in Small-Cell Lung Cancer.
Guangzhou Han, Eunmi Hwang, Fanching Lin, Renee Clift, Daniel Kim, Susan Moran

Mol Cancer Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where Are All the Women in Industry Advisory Boards?
Rachna T Shroff, Karyn A Goodman, Janice M Mehnert, Julie M Vose, Susan E Moran

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
Andrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, Miguel J Gil-Gil, Vinay K Puduvalli, Susan Moran

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma.
Yung Lyou, Jonathan E Rosenberg, Jean Hoffman-Censits, David I Quinn, Daniel Petrylak, Susan Moran

Clin Genitourin Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.
Milind Javle, Sameek Roychowdhury, Robin Kate Kelley, Saeed Sadeghi, Teresa Macarulla, Susan Moran

Lancet Gastroenterol Hepatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
M Teresa Magone, Iris R Hartley, Edmond FitzGibbon, Rachel Bishop, Mike Arango, Susan Moran

Ophthalmology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor.
M Teresa Magone, Iris R Hartley, Edmond Fitzgibbon, Rachel Bishop, Mike Arango, Susan Moran

Ophthalmology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of an Allelic Series at the Ahr Locus Using an Edited Recombinant Approach.
Rachel H Wilson, Patrick R Carney, Edward Glover, Jessica C Parrott, Brenda L Rojas, Susan M Moran

Toxicol Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial Carcinoma.
Yung Lyou, Petros Grivas, Jonathan E Rosenberg, Jean Hoffman-Censits, David I Quinn, Susan Moran

Eur Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia.
Iris R Hartley, Carole B Miller, Georgios Z Papadakis, Clemens Bergwitz, Jaydira Del Rivero, Susan Moran

N Engl J Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
Sumanta K Pal, Dean Bajorin, Nazli Dizman, Jean Hoffman-Censits, David I Quinn, Susan Moran

Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.
Hope S Rugo, Jack A Di Palma, Debu Tripathy, Richard Bryce, Susan Moran

Breast Cancer Res Treat· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model.
Kate R Secombe, Imogen A Ball, Joseph Shirren, Anthony D Wignall, John Finnie, Susan Moran

Cancer Chemother Pharmacol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orchestrated Testing.
Eugenia K Pallotto, John Chuo, Anthony J Piazza, Lloyd Provost, Theresa R Grover, Susan Moran

Am J Med Qual· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Miguel Martin, Frankie A Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy, Susan Moran

Lancet Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustaining SLUG Bug CLABSI Reduction: Does Sterile Tubing Change Technique Really Work?
Eugenia K Pallotto, Anthony J Piazza, Joan R Smith, Theresa R Grover, John Chuo, Susan Moran

Pediatrics· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal pathology in the PPCD1 mouse.
Anna L Shen, Susan M Moran, Edward A Glover, Leandro B Teixeira, Christopher A Bradfield

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a Chromosomal Rearrangement Event with Mouse Posterior Polymorphous Corneal Dystrophy and Alterations in Csrp2bp, Dzank1, and Ovol2 Gene Expression.
Anna L Shen, Susan A Moran, Edward A Glover, Norman R Drinkwater, Rebecca E Swearingen

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interdisciplinary teamwork and the power of a quality improvement collaborative in tertiary neonatal intensive care units.
Theresa R Grover, Eugenia K Pallotto, Beverly Brozanski, Anthony J Piazza, John Chuo, Susan Moran

J Perinat Neonatal Nurs· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant chlorophyll fluorescence: active and passive measurements at canopy and leaf scales with different nitrogen treatments.
M Pilar Cendrero-Mateo, M Susan Moran, Shirley A Papuga, K R Thorp, L Alonso

J Exp Bot· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLUG Bug: Quality Improvement With Orchestrated Testing Leads to NICU CLABSI Reduction.
Anthony J Piazza, Beverly Brozanski, Lloyd Provost, Theresa R Grover, John Chuo, Susan Moran

Pediatrics· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic response of plant chlorophyll fluorescence to light, water and nutrient availability.
M Pilar Cendrero-Mateo, A Elizabete Carmo-Silva, Albert Porcar-Castell, Erik P Hamerlynck, Shirley A Papuga, M Susan Moran

Funct Plant Biol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.
Daniel P Petrylak, Jitendra G Gandhi, William R Clark, Elisabeth Heath, Jianqing Lin, Susan Moran

Invest New Drugs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte circadian clock controls acetaminophen bioactivation through NADPH-cytochrome P450 oxidoreductase.
Brian P Johnson, Jacqueline A Walisser, Yan Liu, Anna L Shen, Erin L McDearmon, Susan M Moran

Proc Natl Acad Sci U S A· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis